000 | 01527 a2200457 4500 | ||
---|---|---|---|
005 | 20250514011130.0 | ||
264 | 0 | _c20011101 | |
008 | 200111s 0 0 eng d | ||
022 | _a0013-7227 | ||
024 | 7 |
_a10.1210/endo.142.10.8437 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKostenuik, P J | |
245 | 0 | 0 |
_aOPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. _h[electronic resource] |
260 |
_bEndocrinology _cOct 2001 |
||
300 |
_a4295-304 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Diseases, Metabolic _xdrug therapy |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlycoproteins _xpharmacology |
650 | 0 | 4 | _aOsteoprotegerin |
650 | 0 | 4 | _aOvariectomy |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xtherapeutic use |
650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
650 | 0 | 4 |
_aTeriparatide _xanalogs & derivatives |
700 | 1 | _aCapparelli, C | |
700 | 1 | _aMorony, S | |
700 | 1 | _aAdamu, S | |
700 | 1 | _aShimamoto, G | |
700 | 1 | _aShen, V | |
700 | 1 | _aLacey, D L | |
700 | 1 | _aDunstan, C R | |
773 | 0 |
_tEndocrinology _gvol. 142 _gno. 10 _gp. 4295-304 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/endo.142.10.8437 _zAvailable from publisher's website |
999 |
_c11486718 _d11486718 |